| Accession | ARO:3003993 |
| Definition | Capreomycin is an aminoglycoside antibiotic, capable of treating a large number of infections but in particular used for killing bacteria causing tuberculosis. |
| SMILES | C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1 |
| PubChem | 122130878 |
| ChEBI | 3371 |
| ChEMBL | CHEMBL2221250 |
| CAS | 11003-38-6 |
| Drug Class | aminoglycoside antibiotic |
| Classification | 2 ontology terms | Show |
| Parent Term(s) | 1 ontology terms | Show + aminoglycoside antibiotic [Drug Class] |
| Sub-Term(s) | 7 ontology terms | Show + cpaA confers_resistance_to_antibiotic + Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to capreomycin confers_resistance_to_antibiotic + Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides confers_resistance_to_antibiotic + Mycobacterium tuberculosis 23S rRNA mutation conferring resistance to capreomycin confers_resistance_to_antibiotic + cph confers_resistance_to_antibiotic + Mycobacterium tuberculosis Rv1258c mutations confer resistance to ethambutol and capreomycin confers_resistance_to_antibiotic + Mycobacterium tuberculosis tlyA mutations conferring resistance to capreomycin confers_resistance_to_antibiotic |
| Publications | Nomoto S, et al. 1977. J. Antibiot. 30(11):955-9 The revised structure of capreomycin. (PMID 73540) |
| Curator | Description | Most Recent Edit |
|---|
